CoChat

Hepatotoxicity of Nucleoside Reverse Transcriptase Inhibitors

Valentina Montessori, Marianne Harris, Julio S. G. Montaner · 2003 · Seminars in Liver Disease

The DOI matches its Crossref record.

Abstract

Hepatotoxicity is an adverse effect of all available classes of antiretrovirals, including nucleoside reverse transcriptase inhibitors (NRTI). A syndrome of hepatic steatosis and lactic acidosis has been recognized as a rare, potentially fatal complication since the advent of NRTI monotherapy in the early 1990s. Today, NRTI remain the backbone of antiretroviral combination regimens, and, with the success of current treatment strategies, exposure to two or more of these agents may occur over a number of years. Hepatic steatosis and lactic acidosis are accordingly being observed more frequently, along with a more recently recognized syndrome of chronic hyperlactatemia. These as well as other adverse effects of NRTI are mediated by inhibition of human DNA polymerase gamma, resulting in mitochondrial dysfunction in the liver and other tissues. Early recognition and intervention are essential to avert serious outcomes.

Overview

Integrity signals

Registry

Crossref · 10.1055/s-2003-39947

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Still being checked.

Cited by

See all 62

Metadata

Authors
Montessori, V., Harris, M., & Montaner, J. S. G.
Affiliations
  • University of British Columbia (CA)
  • BC Centre for Excellence in HIV/AIDS (CA)
Venue
Seminars in Liver Disease
Published
2003
Volume
23
Issue
2
Pages
167-172
ISSN
  • 0272-8087 (ISSN-L)
  • 1098-8971
OpenAlex
W2464563939
Cited by
62
References
0
Citations by year
2026: 1 · 2023: 1 · 2022: 3 · 2021: 4 · 2019: 4 · 2018: 3 · 2016: 3 · 2015: 1 · 2014: 2 · 2013: 3 · 2012: 4
FWCI
3.42
Type
journal article
Language
en
Open access
closed
Locations
  • Seminars in Liver Disease (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
  • Health Sciences › Medicine › Hepatology › Hepatitis C virus research
Keywords
nucleoside reverse transcriptase inhibitors, hepatotoxicity, lactic acidosis, hepatic steatosis, mitochondrial dysfunction, antiretroviral therapy, HIV infection, adverse drug reactions
MeSH terms
Humans, Liver, Mitochondria, Liver, HIV Infections, Reverse Transcriptase Inhibitors, Anti-HIV Agents, Chemical and Drug Induced Liver Injury

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hepatotoxicity of Nucleoside Reverse Transcriptase Inhibitors. https://app.cochat.ai/papers/10.1055/s-2003-39947
The paper
Montessori, V., Harris, M., & Montaner, J. S. G. (2003). Hepatotoxicity of Nucleoside Reverse Transcriptase Inhibitors. Seminars in Liver Disease. https://doi.org/10.1055/s-2003-39947

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.